IndraLab
Statements
USP32 is modified
7
|
Aflatoxin B1 affects USP32
3
|
MiR-19b-3p affects USP32
|
2
Hsa-miR-93-5p affects USP32
2
|
Hsa-miR-519d-3p affects USP32
2
|
Hsa-miR-20b-5p affects USP32
2
|
Hsa-miR-20a-5p affects USP32
2
|
Hsa-miR-17-5p affects USP32
2
|
Hsa-miR-106b-5p affects USP32
2
|
USP32 affects cell population proliferation
|
2
USP32 affects cell growth
|
1
1
USP32 affects Neoplasm Metastasis
|
1
1
USP32 affects Carcinogenesis
|
1
1
Valproic acid affects USP32
1
|
1
|
SiUSP32-386 affects USP32
|
1
SiUSP32-3029 affects USP32
|
1
Raloxifene hydrochloride affects USP32
1
|
Progesterone affects USP32
1
|
Potassium chromate affects USP32
1
|
Phorbol 13-acetate 12-myristate affects USP32
1
|
Paracetamol affects USP32
1
|
Oxaliplatin affects USP32
1
|
Methamphetamine affects USP32
1
|
Hsa_circ_0013880 affects USP32
|
1
Hsa-miR-7156-5p affects USP32
1
|
Hsa-miR-7110-3p affects USP32
1
|
Hsa-miR-6873-3p affects USP32
1
|
Hsa-miR-6833-3p affects USP32
1
|
Hsa-miR-6817-3p affects USP32
1
|
Hsa-miR-548ah-5p affects USP32
1
|
Hsa-miR-526b-3p affects USP32
1
|
Hsa-miR-519c-3p affects USP32
1
|
Hsa-miR-519b-3p affects USP32
1
|
Hsa-miR-519a-3p affects USP32
1
|
Hsa-miR-4796-3p affects USP32
1
|
Hsa-miR-4768-5p affects USP32
1
|
Hsa-miR-4753-3p affects USP32
1
|
Hsa-miR-4696 affects USP32
1
|
Hsa-miR-454-3p affects USP32
1
|
Hsa-miR-4295 affects USP32
1
|
Hsa-miR-4273 affects USP32
1
|
Hsa-miR-3666 affects USP32
1
|
Hsa-miR-3609 affects USP32
1
|
Hsa-miR-301b-3p affects USP32
1
|
Hsa-miR-301a-3p affects USP32
1
|
Hsa-miR-2117 affects USP32
1
|
Hsa-miR-18a-3p affects USP32
1
|
Hsa-miR-130b-5p affects USP32
1
|
Hsa-miR-130b-3p affects USP32
1
|
Hsa-miR-130a-3p affects USP32
1
|
Hsa-miR-124-5p affects USP32
1
|
Hsa-miR-106a-5p affects USP32
1
|
Hexabromocyclododecane affects USP32
1
|
Fulvestrant affects USP32
1
|
Dibutyl phthalate affects USP32
1
|
Cyclosporin A affects USP32
1
|
Cupric oxide affects USP32
1
|
Copper(II) sulfate affects USP32
1
|
Cadmium dichloride affects USP32
1
|
Bta-miR-19b-3p affects USP32
|
1
Benzo[a]pyrene diol epoxide I affects USP32
1
|
Aluminium atom affects USP32
1
|
Afimoxifene affects USP32
1
|
Acrylamide affects USP32
1
|
USP32 affects tumorigenesis chemoresistance carcinoma
|
1
USP32 affects resistance GC cells cisplatin
|
1
USP32 affects process
|
1
USP32 affects mouse model
|
1
USP32 affects migration
|
1
USP32 affects migrated cells
|
1
USP32 affects miR-19b-3p
|
1
USP32 affects metastatic foci lung surfaces
|
1
USP32 affects localization
|
1
USP32 affects growth migration defects investigate functional relevance USP32 SMAD2
|
1
USP32 affects endosomal transport
|
1
USP32 affects colony cells
|
1
USP32 affects cisplatin-resistance cells
|
1
USP32 affects cell cycle
|
1
USP32 affects apoptotic process
|
1
USP32 affects Ubiquitination
|
1
USP32 affects Smad2 Protein
|
1
USP32 affects RP23-33N15.1
1
|
USP32 affects Neoplasm Invasiveness
|
1
USP32 affects GC cell
|
1
RP23-33N15.1 affects USP32
1
|
RNAi affects USP32
|
1
Plant Extracts affects USP32
1
|
MicroRNA let-7a affects USP32
|
1
C60 fullerene affects USP32
1
|
BEP protocol affects USP32
1
|
2-hydroxypropanoic acid affects USP32
1
|
1
|
17beta-estradiol affects USP32
1
|
1,3-dinitrobenzene affects USP32
1
|
(-)-epigallocatechin 3-gallate affects USP32
1
|
2,3',4,4',5-pentachlorobiphenyl affects USP32
1
|